Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 20, 2013

Drug Name	Review Type	Class	Manufacturer
Quillivant XR	New Drug Initial Review	Stimulants/ADHD	Pfizer
Xeljanz	New Drug Initial Review	Rheumatoid Arthritis	Pfizer
Aubagio	New Drug Initial Review	Multiple Sclerosis	Genzyme
Eliquis	New Drug Initial Review	Oral Anticoagulant	Bristol Myers-Squibb
Sklice	New Drug Initial Review	Pediculicide	Sanofi Pasteur
Gattex	New Drug Initial Review	GLP-2	NPS Pharmaceuticals
Oxtellar XR	New Drug Initial Review	Anticonvulsant	Supernus Pharmaceuticals
Tudorza Pressair	New Drug Initial Review	Long-acting Anticholingeric	Forest
Natroba	New Drug Appeal	Pediculicide	ParaPRO
Brilinta	PDL Appeal	Platelet Aggregation Inhibitor	AstraZeneca
Latuda	PDL Appeal	Atypical Antipsychotic	Sunovion